SELECT COUNTRY

VIEW ALL

AFRICA

AMERICAS

ASIA

EUROPE

OCEANIA

ALGERIA ANGOLA ARGENTINA AUSTRALIA AZERBAIJAN BAHREIN BELGIUM BENIN BOLIVIA BOTSWANA BRAZIL BRUNEI BURKINA FASO CAMEROON CANADA CENTRAL AFRICAN REPUBLIC CHAD CHILE CHINA COLOMBIA COTE D’IVOIRE CUBA CZECH REPUBLIC DOMINICAN REPUBLIC DRC ECUADOR EGYPT EQUATORIAL GUINEA ETHIOPIA FINLAND FRANCE GABON GHANA GREENLAND GUATEMALA GUINEA GUYANA HUNGARY ICELAND INDIA INDONESIA IRAN IRAQ ITALY JAMAICA JAPAN KAZAKHSTAN KENYA KUWAIT LESOTHO LIBERIA LIBYA MADAGASCAR MALAWI MALAYSIA MALI MAURITANIE MEXICO MONGOLIA MOROCCO MOZAMBIQUE NAMIBIA NETHERLANDS NICARAGUA NIGER NIGERIA NORWAY PANAMA PAPUA NEW GUINEA PARAGUAY PERU PHILIPPINES POLAND QATAR REPUBLIC OF CONGO RUSSIA RWANDA SAUDI ARABIA SENEGAL SIERRA LEONE SINGAPORE SLOVENIA SOMALI SOUTH AFRICA SOUTH KOREA SPAIN SUDAN SWEDEN TAIWAN TANZANIA THAILAND TOGO TRINDAD & TOBAGO TURKEY TURKMENISTAN UAE UGANDA UKRAINE UNITED KINGDOM UNITED STATES VENEZUELA VIETNAM ZAMBIA ZIMBABWE

SUDAN: LATEST INTERVIEWS MORE INTERVIEWS

Jeff Quartermaine

MANAGING DIRECTOR & CEO, PERSEUS MINING

"Our strong development pipeline has the potential to elevate Perseus to a very different level from where we are positioned today."

Mining

Tanzania

Cote d’Ivoire

Ghana

Sudan

MACIG

Jeff Quartermaine

MANAGING DIRECTOR & CEO, PERSEUS MINING

"Operationally, throughout the year we have systematically been at the top end of our production guidance and below the bottom end of our cost guidance."

SUDAN: LATEST ARTICLES

No Content Found

MACIG 2024 - Pre-Release

November 17, 2023

MACIG 2023 Pre-Release

November 21, 2022

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

MORE PREVIOUSLY PUBLISHED